[[2-(2-Methylpropyl)-3-sulfamoylphenyl]-phenylmethyl] methanesulfonate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: [[2-(2-Methylpropyl)-3-sulfamoylphenyl]-phenylmethyl] methanesulfonate
• 英文别名: [[2-(2-methylpropyl)-3-sulfamoylphenyl]-phenylmethyl] methanesulfonate
• 化学式: C₁₈H₂₃NO₅S₂
• 分子量: 397.5
• InChiKey: HPYGPFZIBVIYRF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  26
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  120
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• Methods for treating skin
  申请人：AVON PRODUCTS, INC.

  公开号：US10076479B1

  公开（公告）日：2018-09-18

  Provided are methods of treating skin with at least two alternating treatment modalities to improve the health and/or diminish signs of aging. Some methods according to the present invention may comprise topically applying at least two separate compositions, in a sequential, rotating, or alternating fashion to overcome adaptation, tolerance, or sensitization phenomena.

  本发明提供了至少两种交替治疗皮肤的方法，以改善皮肤健康和/或减少老化迹象。根据本发明的一些方法，可包括局部使用至少两种不同的组合物，以顺序、轮流或交替的方式来克服适应、耐受或过敏现象。
• TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF
  申请人：Avon Products, Inc.

  公开号：EP3212186A1

  公开（公告）日：2017-09-06
• METHODS FOR TREATING SKIN
  申请人：Avon Products, Inc.

  公开号：EP3265053A1

  公开（公告）日：2018-01-10
• Medemia Nobilis Extracts and Methods of Use
  申请人：AVON PRODUCTS, INC.

  公开号：US20140161909A1

  公开（公告）日：2014-06-12

  The present invention describes methods for improving the appearance of skin, particularly, treating, ameliorating, preventing, delaying, and/or improving one or more signs of aging, by topically applying compositions comprising an extract of Medemia nobilis.
• Topical Compositions and Methods of Use Thereof
  申请人：Avon Products, Inc.

  公开号：US20160122305A1

  公开（公告）日：2016-05-05

  The invention is generally directed to compositions useful for improving the aesthetic appearance of human skin and the use of those compounds for improving the appearance of human skin, including improving skin tone, reducing the appearance of dark circles under the eyes, and reducing inflammation in the skin. The compositions typically comprise adrenergic receptor agonists.